跳至主要内容
临床试验/NCT02562144
NCT02562144已完成4 期

A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults

Isala0 个研究点目标入组 17 人开始时间: 2016年4月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Isala
入组人数
17
主要终点
The pain score of the tested subjects during intravenous cannulation

研究概览

简要总结

The enrolled subjects will get an intravenous cannulation in both elbows. The subject will get before xylocaine spray is placed, the intervention-arm, one intravenous cannulation in one of the elbows, the other intravenous cannulation is placed in the other arm before placebo spray is placed, the control arm. The pain score during insertion of the cannulation, the incidence of adverse events and the success rate and degree of difficulty to place an intravenous cannulation. The subjects and the one who place the cannulations will be blinded to the treatment.

详细描述

The enrolled subjects will get an intravenous cannulation in both elbows. The influence of the left or right-handedness is reduced by randomizing the arms of the subjects in the placebo group or xylocaine group. The subject will get before xylocaine spray is placed, the intervention-arm, one intravenous cannulation in one of the elbows, the other intravenous cannulation is placed in the other arm before placebo spray is placed, the control arm. The pain score during insertion of the cannulation, the incidence of adverse events and the success rate and degree of difficulty to place an intravenous cannulation. The subjects and the one who place the cannulations will be blinded to the treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (aged 18 or older)
  • Signing of the informed consent paper

排除标准

  • Allergy for xylocaine
  • Pregnancy or breast-feeding
  • Peripheral neuropathy
  • Analgesics in the last 24 hours
  • Skin conditions (eczema, psoriasis, infection, or abrasions)
  • Difficulties in verbal communication
  • No intravenous access in both elbows possible (eg status after axillary dissection )

研究组 & 干预措施

Xylocaine spray

Experimental

干预措施: Xylocaine spray (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

The pain score of the tested subjects during intravenous cannulation

时间窗: A few seconds after intravenous cannulation

Visual Analogue Scale (VAS) (0 = no pain, 10 = severe pain)

次要结局

  • Complications or adverse reactions of xylocaine spray or placebo spray(5 minutes after xylocaine spray or placebo and 15 minutes after cannulation)
  • Influence of xylocaine spray in successfully placing an IV cannulation(Before intravenous cannulation)
  • The degree of difficulty in successfully placing an IV cannulation(A few seconds after intravenous cannulation)

研究者

发起方
Isala
申办方类型
Other
责任方
Principal Investigator
主要研究者

J. Datema

Master of Science

Isala

相似试验

A Clinical Trial of Cutaneous Xylocaine Spray to... | 临床试验